|
ZNF828 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.03009822893796E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.3999691123322E-12 |
| Normal-vs-Stage2 |
1.53663999999942E-05 |
| Normal-vs-Stage3 |
1.78162999999731E-05 |
| Normal-vs-Stage4 |
1.28460000003994E-06 |
| Stage1-vs-Stage2 |
5.689200E-01 |
| Stage1-vs-Stage3 |
5.221400E-01 |
| Stage1-vs-Stage4 |
8.821000E-01 |
| Stage2-vs-Stage3 |
9.973600E-01 |
| Stage2-vs-Stage4 |
5.901200E-01 |
| Stage3-vs-Stage4 |
6.076600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.40094619133424E-12 |
| Normal-vs-AfricanAmerican |
1.2973999985455E-08 |
| Normal-vs-Asian |
3.54820000000311E-05 |
| Caucasian-vs-AfricanAmerican |
3.324600E-01 |
| Caucasian-vs-Asian |
6.904400E-01 |
| AfricanAmerican-vs-Asian |
5.133800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63813407283442E-12 |
| Normal-vs-Female |
3.64770000005343E-06 |
| Male-vs-Female |
1.293710E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.1475000029686E-08 |
| Normal-vs-Extreme_Weight |
1.67799107941846E-12 |
| Normal-vs-Obese |
5.17760001539358E-09 |
| Normal-vs-Extreme_Obese |
1.69224999999606E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.202000E-01 |
| Normal_Weight-vs-Obese |
6.178800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.178800E-01 |
| Extreme_Weight-vs-Obese |
1.845590E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.201000E-01 |
| Obese-vs-Extreme_Obese |
4.154600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.27299999944597E-07 |
| Normal-vs-Age(41-60Yrs) |
1.40949996119133E-09 |
| Normal-vs-Age(61-80Yrs) |
1.8268719870207E-12 |
| Normal-vs-Age(81-100Yrs) |
1.43849999689749E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.958800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.118800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.053200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.475770E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.010630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.971200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.65445435129641E-12 |
| Normal-VS-Type2 PRCC |
1.05049999810092E-08 |
| Normal-VS-KIRP CIMP |
3.05960000002159E-06 |
| Normal-VS-Unclassified PRCC |
1.998350E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.543210E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.686600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.672000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.408400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.842200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.254400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.6621374255883E-15 |
| Normal-vs-N1 |
1.143880E-03 |
| Normal-vs-N2 |
8.47989999996912E-07 |
| N0-vs-N1 |
1.945980E-02 |
| N0-vs-N2 |
1.542790E-01 |
| N1-vs-N2 |
1.805220E-04 |
|
|
